Every CVE Search/ Get API key

CVE-2026-21997

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science...

8.5 High

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Attack profile

How easy it is to exploit

Attack vector
Network
Complexity
Low
Privileges needed
Low
User interaction
None

What an attacker can affect

Confidentiality
Low
Integrity
High
Availability
None

Exploit likelihood

0.20%Up 0.2 points since Apr 22, 2026
90%50%10%1%

What each source reports

CVE List Score used 8.5

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Record
CVE-2026-21997
CVSS 3.1
8.5 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
Weakness
CWE-284
Updated
2026-11-02
EUVDEUVD-2026-24293 8.5

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Record
EUVD-2026-24293
CVSS 3.1
8.5 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
Updated
2026-11-02
GitHub AdvisoriesGHSA-fjgq-vg76-2mmp 8.5

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science...

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Record
GHSA-fjgq-vg76-2mmp
CVSS 3.1
8.5 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
Weakness
CWE-284
Updated
2026-11-02
NVD 8.5

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Record
CVE-2026-21997
CVSS 3.1
8.5 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
Weakness
CWE-284
Updated
2026-11-02

Affected products

History

History
RecordedChangedSources
first indexedCVE List, EUVD, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2026-21997 is a high vulnerability (CVSS 8.5) in Oracle Life Sciences Empirica Signal, published April 21, 2026. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.20%, the 10th percentile. No source names a fixed version.

References

MoveEnter Open